Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

MedShift Receives Business Innovation Award Recognition


The Business Innovation Award underscores the company’s commitment to transform the Aesthetics industry through technology and software optimization.

MedShift, a leading medical technology company, is proud to announce its recent recognition with The Aesthetic Industry Association’s Business Innovation Award. This award celebrates the contribution of MedShift’s unique business model within the Aesthetic sector.

The Business Innovation Award recognizes MedShift’s commitment to enrich aesthetic medical device manufacturers, suppliers and practices with high-quality, high-performing solutions that have the power to transform their business operations and help them achieve their goals. This accolade serves as a testament to the hard work, dedication, and vision demonstrated by the entire MedShift team and our Aesthetics suppliers.

“We are thrilled to receive the Business Innovation Award and to be recognized among the best in the Aesthetic industry,” said MedShift’s CEO, Joe Gasque. “This award is a reflection of the tireless efforts of our talented employees, and valued OEM and distributor partners, as well as the trust of our Aesthetic practice partners who focus on exceptional patient care every day.

MedShift has established itself as a leader in the Aesthetic sector, continually pushing the boundaries of what is possible. With a focus on innovation, MedShift has successfully developed a multitude of groundbreaking solutions that have the power to revolutionize Aesthetics and set new industry standards. The Business Innovation Award underscores the company’s commitment to transform the Aesthetics industry through technology and software optimization.

About MedShift

MedShift, a medical technology company founded in 2015 and headquartered in Charlotte, NC, is an emerging leader in the healthcare industry. MedShift is one of the largest and fastest growing solution providers to the aesthetic industry and is differentiated by its technology and software as a service focus. The company brings opportunities to drive growth and scale to medical device manufacturers as well as individual medical providers across various markets, including Dermatology, Gynecology, Plastic Surgery, and MedSpa. MedShift’s business is centered around four business lines, Express Specialty Device Subscription, Connected Product (IoT), Velocity Technology Suite (Enterprise Software as a Service), and the MedShift Store, an online marketplace featuring a range of complementary products and services that streamline the complex supply-and-demand landscape of device consumables and injectables. MedShift’s mission is to drive business transformation and power sales through the use of modern technology. The company currently has partnered with 25 aesthetic manufacturers and distributors, a portfolio of 80+ devices and over 2,000 active medical providers.

Share article on social media or email:

Unitek Learning Celebrates BSN Graduating Class in Boise


Unitek Learning is the parent company of several distinguished learning institutions: Unitek College, Unitek EMT, Unitek Training Healthcare, Eagle Gate College, Provo College, and Brookline College.

We can’t wait to see what they’ll do in their healthcare careers.

In the spring of 2023, 14 exceptional students will graduate from a Bachelor of Science in Nursing (BSN) program in Boise, Idaho. These individuals will attend their pinning ceremony alongside graduates of the Practical Nursing (PN) program and the Masters Entry Nursing Program (MEPN) at the Boise campus. Despite the challenges they faced, these graduates rose to the occasion and completed this blended program.

“We have eight BSN instructors that go above and beyond to support their students. Each instructor applies their own unique and effective teaching philosophy to help establish successful students,” said Pete Traxler, the Campus Director at Boise. “Without the security and support that a formal program provides, it can be almost impossible to succeed. We strive to ensure that our students have room to grow, achieve, and live their best professional lives. Our ultimate goal is to produce skilled graduates and help combat the nursing shortage crisis in the United States.”

The BSN program is ideal for anyone looking to earn their nursing degree and advance their career. Since Eagle Gate College offers a blended-online nursing program, BSN students at Boise can complete some of their courses online. While on campus, students learn from experienced instructors and gain hands-on experience at various facilities. From smaller class sizes to a virtual reality laboratory, the BSN program at Boise is designed to provide each student with an enriching experience.

“We are so thrilled for our graduates in Boise,” said Janis Paulson, Chief Executive Officer at Unitek Learning. “Not only did they enroll in a rewarding but challenging program, but they did so amidst a period of global unrest. It shaped their curriculum and learning experiences. Despite the surreal circumstances, these graduates tackled unusual issues and successfully completed their program. We can’t wait to see what they’ll do in their healthcare careers.”

Unitek Learning is the parent company of several distinguished learning institutions: Unitek College, Unitek EMT, Unitek Training Healthcare, Eagle Gate College, Provo College, and Brookline College. Unitek programs teach the clinical practices and theory used in the field today. Equipped with a multitude of sought-after skills, Unitek graduates are prepared to excel in many of the fastest-growing careers in healthcare and nursing.

Share article on social media or email:

By Mimicking Nature, Scientists Build a Better Artificial Lung


By mimicking blood flow patterns in the human body, engineers improve the safety and efficacy of artificial lungs, a potential benefit to critical care patients and combat casualties.

“Here we report on development and demonstration of the first microfluidic respiratory assist device at a clinical scale, demonstrating efficient oxygen transfer at blood flow rates of 750 milliliters per minute, the highest ever reported for a microfluidic device,” said Draper and AREVA.

A mechanical device for oxygenating blood outside the human body, essentially functioning as an artificial lung, is taking a leap forward fifty years after its debut. The original device in clinical use today, called ECMO, which stands for extracorporeal membrane oxygenation, has been reimagined by bioengineers at Draper who took their cues from the way the human body oxygenates blood in the branching circulatory system.

The results, published in the journal Advanced Science, demonstrate a new configuration of an ECMO device that delivers oxygen and removes carbon dioxide in blood that travels through branching microchannels. The study, by researchers at Draper and The Autonomous Reanimation and Evacuation (AREVA) research program and innovation institute of the Geneva Foundation, is a “key step toward translation of this technology to the clinic for treatment of a range of lung diseases,” said Jeff Borenstein, Ph.D., a laboratory fellow at Draper. Critical care patients such as premature infants, transplant and pneumonia patients and others suffering respiratory failure and related conditions may benefit, he added.

ECMO technology was developed in the late 1960s, and its main purpose was to serve as a temporary bypass machine to support gas exchange for patients undergoing heart surgery. The central functional unit of current ECMO systems are a hollow fiber membrane oxygenator (HFMO), a device designed to add oxygen and remove carbon dioxide from the blood by passing it over a fiber bundle in a specially designed container. Since its inception, the safety and availability of ECMO has been limited by the complexity of the blood circuit, hemocompatibility of the oxygenator and circuit components and complications such as clotting, bleeding and inflammatory responses.

While only the largest and most specialized medical centers currently offer ECMO, the demand for ECMO spiked during the pandemic, since the conventional means for respiratory support— mechanical ventilation—resulted in poor patient outcomes and high mortality. A safer and simpler-to-use device could bring the life-saving power of heart and lung bypass to civilian patients when ICU beds are limited—and to military casualties on the battlefield. However, current ECMO based on HFMO technology requires a large team of highly specialized personnel to administer the treatment and deal with frequent complications.

Draper addressed ECMO’s challenges by developing a three-dimensional branching network of blood channels that mimic key features of the human body’s microcirculation, an approach that is not possible with conventional HFMO cartridge technology. They focused on scalable operation at clinically relevant flow rates and stable, long-term performance. They used microfluidic technology, a specialty at Draper, to control for flow behavior, fluidic resistance, shear stresses and uniform distribution across the microfluidic device.

“Here we report on development and demonstration of the first microfluidic respiratory assist device at a clinical scale, demonstrating efficient oxygen transfer at blood flow rates of 750 milliliters per minute, the highest ever reported for a microfluidic device,” the authors said. “One of the most promising routes of innovation in ECMO entails the use of microfluidics technology for the design and construction of the oxygenator, with the potential to replace the HFMO with a branching network of microchannels that recapitulates key aspects of the lung vasculature.”

Brett Isenberg, a co-author of the paper and a principal member of the technical staff, said, “One of the most common criticisms of the microfluidic approach is that it will never be capable of operating at clinically relevant flow rates. However, with this study, we have taken the first major step towards demonstrating the viability of microfluidic oxygenators at a scale and duration that is suitable for human patients.”

The research is a collaboration between Draper and the AREVA Research Institute in San Antonio, Texas. “AREVA is a pioneer in developing and testing groundbreaking life-saving interventions in critical care and, specifically, for life-threatening injuries leading to lung and multiorgan failure such as seen in combat casualties and severely injured civilians,” said Andriy Batchinsky MD, founding director of AREVA and co-principal investigator in charge of clinically-relevant testing of the microfluidic oxygenator that Draper developed.

“While ECMO has been around for a while, it is not widely adopted in combat scenarios or in the clinical environment,” says Dr. Teryn Roberts, Dr. Batchinsky’s colleague and research partner, and a principal investigator at AREVA and co-investigator on this study overseeing biocompatibility assessment. “Draper’s innovations in solutions for the warfighter, including ECMO, was a natural fit for our work at AREVA where we specifically focus on development and testing of novel biocompatible materials for extracorporeal life support (ECLS), as well as the effects of ECLS on coagulopathy and endothelial damage following trauma.”

Initially launched with internal funding, Draper’s biomimetic ECMO device advanced from lab to bench scale with funding from the National Institutes of Health, Department of Defense and commercial device manufacturers. In 2021, Draper’s advancements received recognition from the American Society for Artificial Internal Organs.

The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by The Assistant Secretary of Defense for Health Affairs endorsed by the Department of Defense, in the amount of $4,9111,476.00, through the Peer Reviewed Medical Research Program under Award Number W81XWH1910518. Opinions, interpretations, conclusions, and recommendations contained herein are those of the author(s) and are not necessarily endorsed by the Department of Defense. In conducting research using animals, the investigator(s) adhere(s) to the laws of the United States and regulations of the Department of Agriculture.

Visit Draper.com.

Share article on social media or email:

FDA green-lights bionic pancreas studied at UT Health Science Center San Antonio, University Health


“We don’t want to call this a pump. It is more. It is AI for insulin delivery.” —Jane Lynch, MD, of The University of Texas Health Science Center at San Antonio

While it won’t cure children of type 1 diabetes, the “bionic pancreas,” an artificial intelligence-powered system cleared May 19 by the U.S. Food and Drug Administration, will relieve youth and their parents of constant worries over estimating insulin doses and carb intake from food.

“We don’t want to call this a pump. It is more. It is AI for insulin delivery,” said Jane Lynch, MD, professor of pediatric endocrinology and diabetes at The University of Texas Health Science Center at San Antonio. Lynch, faculty in the health science center’s Joe R. and Teresa Lozano Long School of Medicine, treats children affected by type 1 diabetes at University Health’s Texas Diabetes Institute on San Antonio’s West Side.

One of few sites that studied the system in children

The pediatric endocrinology team at the University Health Texas Diabetes Institute was one of the first vanguard groups of researchers to study the bionic pancreas during a clinical trial reported in the New England Journal of Medicine in October 2022. This experience with the device’s implementation in patients allows the team to be the first in South and Central Texas to offer it to more children.

“We are absolutely thrilled to have the opportunity to launch the bionic pancreas in San Antonio,” said Rabab Jafri, MD, pediatric endocrinology and diabetes specialist in the Long School of Medicine and at University Health. “This is a huge step forward for young people in the management of type 1 diabetes.”

510(k) premarket clearance pathway

The FDA reviewed the bionic pancreas and associated AI software through the 510(k) premarket clearance pathway. The system is cleared for people 6 years of age and older who have type 1 diabetes.

In a press release, Jeff Shuren, MD, JD, director of FDA’s Center for Devices and Radiological Health, said the May 19 clearance “will provide the type 1 diabetes community with additional options and flexibilities for diabetes management and may help to broaden the reach of automated insulin dosing technology.”

Simpler way to keep track

The system, made by a Massachusetts medical technology company, requires only the input of the wearer’s body weight to get started. The automated insulin-delivery system is paired with a continuous glucose monitoring system. At mealtimes, users estimate their carbohydrate intake simply as small, medium or large.

“Instead of having preset insulin dosing, this device enables AI algorithms to learn a patient’s insulin requirements,” Lynch said. “It is unique and innovative.”

Stress of constant vigilance

In people with type 1 diabetes, the pancreas does not make insulin, the hormone that regulates blood glucose. The result is a lifestyle of monitoring glucose levels each day and taking insulin via injections or through an insulin pen or pump. A healthy diet and exercise are also necessary for glucose control.

“At the Texas Diabetes Institute on Zarzamora Street, we care for predominantly Hispanic families, and we see the parents’ struggles to maintain their children’s sugars,” said Ruby Favela-Prezas, family nurse practitioner in the pediatric endocrinology practice. “Some youths adjust well, but others really struggle. For every young person with type 1 diabetes, the constant management that is required can be very stressful, so to have a system that is automatic in ensuring the children’s safety and well-being through regulated glucose levels is truly a dream come true.”

Size of a cell phone

The device uses an attached plastic infusion set that communicates with a sensor to provide insulin in response to continuous blood sugar patterns. The device is the size of a cell phone and is typically worn on the belt.

“The AI algorithm adjusts to the individual needs of each user,” Lynch said. “It is revolutionary, and our team is delighted to share this technology to reduce the daily burden of care for our patient who have type 1 diabetes here in our city and in South and Central Texas.”

About The University of Texas Health Science Center at San Antonio

The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is one of the country’s leading health science universities and is designated as a Hispanic-Serving Institution by the U.S. Department of Education. With missions of teaching, research, patient care and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have graduated more than 42,200 alumni who are leading change, advancing their fields and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways “We make lives better®,” visit UTHealthSA.org.

Stay connected with The University of Texas Health Science Center at San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.

About University Health

University Health is San Antonio’s only locally owned health system and the only academic medical center in South Texas. Its University Hospital serves as the region’s Level I trauma center for adults and children, and is the only area hospital to be state-designated at the highest level for both its Maternity Center and Neonatal Intensive Care Unit. Outpatient care is provided through a comprehensive network of urgent, primary and specialty care centers. For more than 100 years, University Health has been committed to delivering compassionate, culturally competent and high-quality health care, based on a strong foundation of outcomes‐based research and innovative teaching. Learn more at UniversityHealth.com. Follow us on Twitter and Facebook.

Gain insight into effective treatments and health trends through our blog HealthFocusSA.

Share article on social media or email:



Litmus Health Cofounder and Chief Scientific Officer Appointed as Chairman of the Clinical Research Data Sharing Alliance


Since its founding in 2021, the CRDSA has been focused on serving the clinical data sharing ecosystem by addressing the challenges in the life sciences data sharing ecosystem.

Litmus Health, the research-ready infrastructure platform for wearables and sensor data, today announced that Cofounder and Chief Scientific Officer Dr. Samuel Volchenboum has been appointed as chairman of the Clinical Research Data Sharing Alliance (CRDSA). In his role, Dr. Volchenboum will lead the organization’s board of directors in maximizing the strategic impact of the organization in its push to accelerate drug discovery through the use of high-quality data in the clinical trials process.

Since its founding in 2021, the CRDSA has been focused on serving the clinical data sharing ecosystem by addressing the challenges in the life sciences data sharing ecosystem. Some of the biggest issues are rooted in inconsistent data standards and lack of best practices. With an unprecedented amount of data available to clinical researchers — including relatively new data sources like wearables and sensors — addressing these challenges has never been more pressing. The growing clinical trial software market alone speaks to the tremendous opportunity that lies in maximizing the usability and interoperability of trial data.

“The advancements in data collection and applications over the past decade have presented a tremendous opportunity to rapidly accelerate drug discovery, but there are critical challenges that must be addressed to make the most of these advancements,” said Dr. Volchenboum. “The lack of current data best practices — especially in regards to standards and sharing — means that valuable life-saving insights are locked away in data that is difficult or impossible to use. The CRDSA is addressing these problems head-on by bringing together the best minds from the public and private sectors to develop actionable solutions. I am honored to be serving as chairperson of the organization’s board of directors.”

In addition to serving as Cofounder and Chief Scientific Officer to Litmus Health, Dr. Volchenboum currently serves as Director of Data for the Common Good and their flagship project, the Pediatric Data Commons at the University of Chicago. With his extensive experience in developing clinical research protocols, Dr. Volchenboum is uniquely positioned to lead the CRDSA board and help establish standards for the industry’s future.

To learn more about the CRDSA and its mission, visit crdsalliance.org. To learn more about how Dr. Volchenboum and Litmus Health are working to provide end-to-end solutions for clinical trial data capture, monitoring, and analysis, visit litmushealth.com.

About Litmus Health

Litmus Health provides end-to-end solutions for clinical trial data capture, monitoring, and analysis. We are research-ready infrastructure for wearables and sensor data. Our goal is to help researchers increase the certainty of their conclusions and describe the full value of their digital clinical trials.

To learn more, visit litmushealth.com.

Share article on social media or email:

Meta Quest 2 Comfort Vue™ System Can be Optimized as a Virtual Travel Platform to Reduce Elderly Social Isolation


“No other current VR/Metaverse platform can provide the functionality features which make the Comfort Vue™ stationary boundary system an ideal virtual travel platform for older adults.”

VRComfort Labs stated the most vulnerable are those who are over the age 65, live alone, in nursing homes or assisted living centers. They may only interact socially with a couple other residents, care takers and an occasional visiting family member. For single seniors and couples who live in retirement communities and may not be as lonely, the virtual travel platform can still provide emotional and mental benefits.

VRComfort Labs further stated there are companies such as MyndVR, Rendever, SilVR Adventures, VivaVita, and Viarama, who address similar issues and have some decent apps and content. VRComfort Labs reviewed current solutions and believes although content can be good, the delivery system is not. Other than MyndVR ,which utilizes HTC Vive Flow glasses, solution providers require the user to strap on a full-size VR headset. One of the biggest complaints about VR headset engagement is the discomfort caused by pressure on the face. For a senior citizen user, the physical discomfort can be even worse.

The VR Comfort Vue™ platform eliminates head motion sickness, head strap discomfort and allows quick and easy headset entry, exit, and re-entry, for taking take momentary immersion breaks. All three are vital functionality features for a senior citizen user to have an enjoyable virtual travel experience.

No other current VR/Metaverse platform can provide the functionality features which make the Comfort Vue™ stationary boundary system an ideal virtual travel platform for older adults. Alternative solutions can involve more expensive VR headsets, yearly subscriptions, and require a health care “tour guide.” The VR Comfort Vue™ platform can be adapted to accept other headsets, but is plug and play with Quest 2 which can use the $9.99 world travel Wander app

Share article on social media or email:

Set The Expectation Founder and Professional Football Player James Smith Williams Addressed the Eighth Army Sexual Harassment/Assault Response and Prevention (SHARP) Program in South Korea


News Image

Men’s engagement is critical to end incidents of sexual assault and interpersonal violence.

Earlier this month, Brenda Tracy, survivor and founder of Set The Expectation (STE), and James Smith-Williams, NFL player and STE Champion, spoke at the Eighth Army Sexual Harassment/Assault Response and Prevention (SHARP) Program at Humphrey’s Base in South Korea.

Set the Expectation is a national nonprofit dedicated to ending sexual and interpersonal violence.

During the program on May 8 – 11, Tracy and Smith-Williams spoke to 300 military leaders including SHARP professionals. In a session called “Building Safer Culture: A Survivor Perspective”, Tracy shared her story while emphasizing topics of culture building and sexual violence prevention. Smith-Williams spoke on the importance of using his platform and voice to act as an ally to survivors, and what it looks like to engage in the work of sexual violence prevention as a man and a professional athlete.

“Attending events like SHARP is important and beneficial for our mission at Set The Expectation,” said founder, Brenda Tracy. “Men’s engagement is critical to end incidents of sexual assault and interpersonal violence. Being able to engage with large groups and other programs allows us to make tangible progress towards our goal.”

While in South Korea, Tracy and Smith-Williams also spoke at Humphreys High School, presenting to approximately 100 students in grades 11 and 12.

Set The Expectation has already begun to make an impact nationwide. Speaking at the SHARP event is only one of many opportunities of prevention work STE sets out to do. Continuing to work with the military and other community outreach programs ensures the growth and awareness of STE mission.

About Set The Expectation (STE):

Set The Expectation (STE), founded by Brenda Tracy, is a national nonprofit organization dedicated to ending sexual and interpersonal violence through prevention work with men, advocacy, and engagement with agencies serving survivors and their families. For more information about STE visit https://www.settheexpectation.org/.

Share article on social media or email:

Virtual Eating Disorder Treatment Specialist, Earth’s Edge Wellness, Now Offering Treatment for Mental Health Conditions and Drug/Behavioral Addictions


News Image

“When our body and mind are accessed in tandem as the connected system that they are, holistic and sustainable wellness are natural outcomes,” says Yoni Banayan.

Founder, Yoni Banayan, a nationally licensed marriage and family therapist is accompanied by a team of experts at Earth’s Edge Wellness specializing in psychotherapy, reiki, shamanism, yoga, nutritional coaching, Ayurvedic practices and coaching. Earth’s Edge Wellness practitioners believe in consistent self-development, bridging the gap between holistic and scientifically informed treatment. This experienced team of leading holistic and traditional practitioners provides clients with the tools they need to overcome many issues. Working together, the staff designs individualized treatment plans to help address blockages getting in the way of taking care of the body and mind, such as the disconnection from soul/consciousness, disconnect from the body’s natural cues, lack of education about nutrition and mental hygiene and lastly a misaligned relationship with the mind and body. Those with panic disorder, anxiety and depression require prompt treatment, and Earth’s Edge Wellness can offer solutions to help resolve these and other mood conditions. The team also treats borderline personality disorder, where thoughts and feelings about yourself and others are disrupted, making it challenging to carry out normal day-to-day activities. Using various techniques, Earth Edge Wellness can also help patients overcome drug or behavioral addiction. Yoni Banayan and his staff believe that when people are taught to reconnect with their body, healing occurs as a natural byproduct of any living organism. People do not need to know how to heal, they need to know what healing looks like and how to remove the illness or programming getting in the way of their natural functioning.

“When our body and mind are accessed in tandem as the connected system that they are, holistic and sustainable wellness are natural outcomes,” says Yoni Banayan.

More About Earth’s Edge Wellness:

Earth’s Edge Wellness’ approach is simple. They talk to people to see what steps are needed. They then gather their team of people with aligned skill sets and personalities to develop treatment plans that address specific issues, using techniques that involve the body as well as the unconscious mind. Earth’s Edge clients choose their own treatment modalities and ideal treatment team based on a schedule that works for them. With Earth’s Edge Wellness, patients can create a long-term support system to get back to living life. For more information, please call 702-582-9474 or visit http://www.earthsedgewellness.com.

Share article on social media or email:

Beverly Hills, CA’s, Los Angeles Plastic Surgery Recognized as “One of the Top 10 Cosmetic Clinics in the World,” by The Luxe Insider


News Image

“It is an honor to once again be recognized by The Lux Insider. My team and I always strive to create amazing, long-lasting results for patients safely and without pain,” says Dr. John Anastasatos.

Trusted and well-known for highlighting the very best in the luxury travel and lifestyle industry, The Lux Insider has selected Dr. John Anastasatos’ premier plastic surgery practice for this incredible honor. His plastic surgery clinic in California joins nine other practices from across the globe. For the last 15 years, Dr. John Anastasatos has operated one of the largest and most successful plastic surgery clinics in Beverly Hills, CA, and since 2021, he has been operating his own plastic surgery clinic in Athens, Greece. Dr. Anastasatos is a global leader in the field of plastic surgery with an international clientele who travel near and far to benefit from his skill and talent. His practice offers advanced surgical aesthetic procedures, including his innovative, niche percutaneous facelift, “scarless facelift”, and minimally invasive facelift. Dr. Anastasatos will also perform endoscopic brow lift and facelift, lip-lift, high-definition liposculpture, minimal incision breast augmentation, endoscopic abdominoplasty, body contouring and injectables. Many of his plastic surgeries are performed endoscopically and under local anesthesia, which results in a lower risk to his patients and offers a shorter healing time.

Link to profile- http://www.theluxeinsider.com/lifestyle/top-10-cosmetic-clinics-in-the-world/

“It is an honor to once again be recognized by The Lux Insider. My team and I always strive to create amazing, long-lasting results for patients safely and without pain,” says Dr. John Anastasatos.

More about Los Angeles Plastic Surgery:

At Los Angeles Plastic Surgery, John Anastasatos MD, FACS, is highly regarded for his skill in cosmetic, reconstructive and revision procedures, including gold-standard facelifts, breast augmentations, body lift procedures, liposuction and non-surgical treatments. Raised in the United States but with family roots in Athens, Greece, Dr. John Anastasatos has earned many accolades, including being one of America’s Most Honored Doctors Top 5% – US News and World Report, Castle Connolly designated him as a top plastic surgeon in the US for the years 2019-2023 and he is recognized as one of the “Best plastic surgeons in the world” by the Lux Insider. The United States Congress has even honored him for his contributions in plastic surgery and charity service. An honors graduate of Brown University, Dr. Anastasatos trained in general and plastic surgery at Columbia University in NYC and additionally in plastic surgery and microsurgery at the University of Alabama- Birmingham. To schedule a consultation with Dr. John Anastasatos or for more information on his practice location in Beverly Hills, CA, (436 North Bedford Drive, Suite 215) or in Athens, Greece, please call (310) 888-4048, or visit his website http://www.LosAngelesPlasticSurgery.com.

Share article on social media or email:

New Book Inspires Readers to Invest in Potentially Lucrative Opportunities in Cancer Stocks While Making a Difference


News Image

“This book was written to inspire, educate, and equip the reader,” Broadus said. “Particularly those sensitive to the perils of cancer, whether faced directly or indirectly.”

Author Eric Shea Broadus, survivor, and investment advisor representative, promotes the benefits of investing in cancer stocks as a wise financial decision and a powerful way to join in the fight against the disease. Broadus lays the foundational knowledge required to help people build solid portfolios in his new book, “Invest in Cancer Stocks: Make Money and Make a Difference.”

Drawn from decades of experience in the financial area, Broadus’ book highlights why supporting companies seeking to fight, treat, and cure cancer is crucial. He provides an overview of the cancer industry and the various investment opportunities available, describing that companies dedicated to fighting cancer have produced positive financial returns for many investor portfolios. Guidance is offered for readers to build a profitable portfolio, consisting of oncology stocks, real estate investment trusts, and health insurance stocks.

“This book was written to inspire, educate, and equip the reader,” Broadus said. “Particularly those sensitive to the perils of cancer, whether faced directly or indirectly.”

Broadus understands the devastating results that cancer can have on individuals and families. He hopes to inspire readers to acknowledge the disease’s impact and take action to fight against it.

“Although I begin by discussing my own cancer journey that led to the creation of this literary work,” Broadus said, “the primary objective of this book is to add measurable financial value to the stock investor.”

“Invest in Cancer Stocks: Make Money and Make a Difference”

By Eric Shea Broadus

ISBN: 9781664287907 (softcover); 9781664287907 (hardcover); 9781664287891 (electronic)

Available at WestBow Press, Amazon and Barnes & Noble

About the author

Eric Shea Broadus is a leukemia survivor and the founder and investment advisor representative at Can Serve Free LLC, an investment advisory firm. He earned a Bachelor of Arts in Economics from Indiana University-Purdue University Indianapolis and a Master of Arts in International Relations from Johns Hopkins University. Broadus holds an investment advisory license and has more than 20 years of experience in various finance roles. He lives with his wife, Liliana, in Ga. To learn more, please visit http://www.investincancerstocks.com.

General Inquiries:            

LAVIDGE – Phoenix                        

Taylor Moralez

Tmoralez@lavidge.com

Share article on social media or email: